Crizotinib (Crizotinib) Price 2024

Crizotinib is a drug used to treat certain types of metastatic non-small cell lung cancer (NSCLC). It is also indicated to treat certain types of relapsed or refractory anaplastic large cell lymphoma (ALCL), including adults and children 1 and older. Crizotinib is also indicated for the treatment of certain types of unresectable, recurrent or refractory inflammatory myofibroblastic tumor (IMT), a cancer that often occurs in mucosal tissues such as the abdomen, lungs, bladder, stomach, uterus, liver or intestines and is not treatable with surgery or has failed to improve or recurs with previous treatments in adults and children 1 year and older.

Crizotinib belongs to the kinase inhibitor class of drugs. It works by blocking the effects of certain naturally occurring substances that may be necessary to help cancer cells proliferate. By inhibiting the action of these substances, crizotinib slows the growth and spread of tumors.

In China, crizotinib is already on the market and included in medical insurance, and patients can purchase it at local hospital pharmacies. The latest domestic selling price of the German original version of crizotinib is approximately 5,000-15,000 yuan. The latest selling price of overseas original research version of crizotinib is about 10,000 multiples. In addition, in places such as Laos and Bangladesh, there are also officially marketed generic drugs to choose from. The ingredients of the drugs are basically the same as those of the original drugs, and the price is about two to three thousand yuan. For patients, crizotinib can be purchased through formal and legal overseas channels.

Patients should be careful when purchasing medications to ensure they are purchased from legal sources and follow the recommendations and guidance of their doctors. At the same time, in view of the special nature of the drug, patients need to consult with their doctor or pharmacist before purchasing to understand the correct use, dosage and precautions of the drug.